ECM
DAWN

ExodusPoint Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

ExodusPoint Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,321
Closed -$366K – 1660
2025
Q4 		$366K Sell
39,321
-21,600
-35% -$180K ﹤0.01% 1262
2025
Q3 		$429K Sell
60,921
-259,296
-81% -$1.78M ﹤0.01% 1226
2025
Q2 		$2.08M Buy
320,217
+296,480
+1,249% +$2.04M 0.02% 732
2025
Q1 		$188K Sell
23,737
-191,400
-89% -$2.06M ﹤0.01% 1307
2024
Q4 		$2.73M Buy
+215,137
New +$2.99M 0.02% 606
2024
Q3 		– Sell
-14,873
Closed -$205K – 1711
2024
Q2 		$205K Sell
14,873
-82,748
-85% -$1.21M ﹤0.01% 1390
2024
Q1 		$1.61M Buy
97,621
+56,718
+139% +$849K 0.01% 789
2023
Q4 		$597K Sell
40,903
-183,706
-82% -$2.23M ﹤0.01% 983
2023
Q3 		$2.76M Buy
224,609
+37,424
+20% +$488K 0.03% 568
2023
Q2 		$2.23M Buy
+187,185
New +$2.44M 0.02% 766
2023
Q1 		– Sell
-65,929
Closed -$1.42M – 1817
2022
Q4 		$1.42M Buy
65,929
+53,026
+411% +$1.09M 0.02% 791
2022
Q3 		$258K Sell
12,903
-10,100
-44% -$215K ﹤0.01% 1563
2022
Q2 		$412K Buy
+23,003
New +$238K 0.01% 1429
2021
Q3 		– Sell
-9,372
Closed -$213K – 2219
2021
Q2 		$213K Buy
+9,372
New +$196K ﹤0.01% 1948

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

ExodusPoint Capital Management's DAWN Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q1 2026, closing a stake of 39,321 shares — an estimated $366K sold.

ExodusPoint Capital Management first reported a position in DAWN in Q2 2021 and held it in 14 quarters. The position peaked at $2.76M in Q3 2023. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Day One Biopharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 39,321 Day One Biopharmaceuticals shares in Q1 2026, an estimated $366K.
  • ExodusPoint Capital Management first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 14 quarters.
  • ExodusPoint Capital Management's Day One Biopharmaceuticals position peaked at $2.76M in Q3 2023.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.